Printer Friendly

GOLIATH MARVEL FILES LAWSUIT AGAINST DEFIANT DAVID -- ELEVENTH HOUR ATTEMPT TO STOP FAST START OF COMIC RIVAL --

 NEW YORK, Aug. 3 /PRNewswire/ -- A lawsuit charging trademark infringement was filed today in United States District Court, Southern District in Manhattan by Marvel Comics Limited, part of the Marvel entertainment empire, against Defiant, the six-month-old start-up comic brainchild of Jim Shooter, the former editor-in-chief of Marvel. Shooter, 41, last locked horns with Marvel's current chairman, Ronald Perelman, in 1988 when both Shooter and Perelman were suitors for the company. Today's lawsuit seeks a preliminary injunction on an expedited basis, which could result in a judge's decision with two weeks.
 Marvel's suit maintains that the name Warriors of Plasm(TM) infringes on its alleged trademarks rights, first claimed in the United Kingdom for a character, Plasmer. The comic book series which features the character has not appeared and is not expected to appear in this country until late September. In June, Defiant responded to Marvel's concerns by changing the name of its series from Plasm(TM) to Warriors of Plasm, as part of what Shooter termed at the time a "gentlemanly resolution of the issue.
 The suit comes just as the first issue of Defiant's first comic, Warriors
of Plasm No. 1, arrives in comic book stores throughout the country. The first offering from Shooter's new company, Warriors of


Plasm No. 1 has captured approximately 2 percent of the market. Marvel claims its sales routinely account for about 50 percent of the comic book market.
 "It is difficult to conceive how Marvel believes that our trademark title, named for the world of Plasm, or the trademark Warriors of Plasm, infringes on a U.K. character called Plasmer, hero of a book which has yet to be published," says Shooter. "It is easier to believe that they are simply concerned about our fast take-off in a market they dominate. They are aggressive competitors and turf warriors and this type of 'spoiler' behavior right at the beginning of our launch is a classic Marvel technique. We intend to fight this in both the courts of law and public opinion."
 -0- 8/3/93
 /CONTACT: Tricia Morsch or Daniel Urbas of The Newlin Company, 212-689-0777, for Defiant/
 (MRV)


CO: Defiant ST: New York IN: ENT SU:

SH-SM -- NY014 -- 8748 08/03/93 09:07 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 3, 1993
Words:372
Previous Article:WEATHERFORD INTERNATIONAL REPORTS RESULTS
Next Article:HEMOSOL AND DUTCH RED CROSS TO COLLABORATE ON RESEARCH AND DEVELOPMENT OF HUMAN BLOOD SUBSTITUTE PRODUCT
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters